Segmentation by type distinguishes the underlying technological architectures that power Intelligent Medical Insurance Expense Control Systems. Rule‑based engines, still responsible for roughly 45 % of deployments, rely on deterministic logic trees and predefined policy matrices, offering transparency and ease of regulatory compliance but limited adaptability to novel fraud patterns. AI‑driven platforms, now capturing about 35 % of the market, employ machine learning models—such as gradient boosting and deep neural networks—to predict claim anomalies, optimize reimbursement pathways, and continuously refine risk scores from large‑scale data feeds. Hybrid solutions, combining rule‑based safeguards with AI‑enhanced analytics, occupy the remaining 20 %, delivering a balance of interpretability and predictive power for complex claim environments. Each type contributes uniquely to market valuation: rule‑based systems dominate legacy installations, AI platforms drive premium growth through efficiency gains, and hybrids expand the addressable base by mitigating adoption barriers. This taxonomy clarifies competitive positioning and informs strategic R&D allocation.